Simultaneous determination of cefatrizine and clavulanic acid in dog plasma by HPLC

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 1, 2004, Pages 221-231

  Choi, Han Gon ^a   Jun, H Won ^b   Kim, Dae Duk ^c   Sah, Hongkee ^d   Yoo, Bong Kyu ^a   Yong, Chul Soon ^a  

^a Yeungnam University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF GEORGIA   (United States)

^d Catholic University of Daegu   (South Korea)

Author keywords

1,2,4 Triazole; Cefatrizine; Clavulanic acid

Indexed keywords

1,2,4 TRIAZOLE; CEFATRIZINE; CLAVULANIC ACID; SULFANILAMIDE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; DERIVATIZATION; DOG; DRUG DETERMINATION; DRUG ISOLATION; DRUG SPECIFICITY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NONHUMAN; PLASMA; PRIORITY JOURNAL; STANDARD; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANIMALS; CALIBRATION; CEFATRIZINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLAVULANIC ACID; DOGS; DRUG STABILITY; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 1642368291     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.01.010     Document Type: Article

References (37)

1. Greenwood D., O'Grady F., Baker P. J. Antimicrob. Chemother. 5:1979;539-547.
2. Reading C., Hepburn P. Biochem. J. 179:1979;67-76.
3. Neu H.C. Science. 257:1992;1064-1073.
4. Reed M.D. Ann. Pharmacother. 32:1998;s17-s21.
5. Yang Y., Rasmussen B.A., Shlaes D.M. Pharmacol. Ther. 83:1999;141-151.
6. Grant E.B., Guiadeen D., Baum E.Z., Foleno B.D., Jin H., Montenegro D.A., Nelson E.A., Bush K., Hlasta D.J. Bioorg. Med. Chem. Lett. 10:2000;2179-2182.
7. Qadri S.M.H., Ueno Y., Cunha B.A. Chemotherarpy. 42:1996;334-342.
8. Luzzaro F., Perilli M., Amicosante G., Lombardi G., Belloni R., Zollo A., Bianchi C., Toniolo A. Int. J. Antimicrob. Agents. 17:2001;131-135.
9. Turck M. J. Antimicrob. Chemother. 22(Suppl. A):1988;45-62.
10. Todd P.A., Benfield P. Drugs. 39:1990;264-307.
11. G.K. McEvoy (Ed.), AHFS Drug Information 95®, American Society of Health-System Pharmacists, MD, USA, 1995, pp. 292-297.
12. Miller L.A., Ratnam K., Payne D.J. Curr. Opin. Pharmacol. 1:2001;451-458.
13. Kanazawa Y., Kuramata T., Matsumoto K. Jpn. J. Antibiot. 36:1983;709-716.
14. Carlone N.A., Cuffini A.M., Forno Pizzoglio M., Cavallo G. Drugs Exp. Clin. Res. 11:1985;447-451.
15. Santella P.J., Tanrisever B. Drugs Exp. Clin. Res. 11:1985;441-445.
16. Verhaegen J., Verbist L. Acta Clin. Belg. 47:1992;377-386.
17. Miyazaki M., Ogushi O., Kajiki A., Takamoto M., Ishibashi T. Jpn. J. Antibiot. 34:1981;955-958.
18. Ueda K., Tsuto H., Yamamoto T., Minami Y., Muraoka M., Tsushima T., Morihana T., Nagata K., Nakao K., Shimada K. Jpn. J. Antibiot. 34:1981;1092-1097.
19. Cremonesi G., Tarantino V., Stura M., Ciampini M. Clin. Ther. 9:1987;263-266.
20. Song S.M., Lee J.H., Lee N.Y. Kor. J. Clin. Microbiol. 2:1999;194-198.
21. Choi S.H., Kim J.Y., Kim G.W., Kim W.B., Shim M.J., Lee K.W., Chong Y.S. J. Appl. Pharmacol. 7:1999;44-53.
22. Crombez E., Van Der Weken G., Van Der Bossche W., De Moerloose P. J. Chromatogr. A. 173:1979;165-173.
23. Haginaka J., Yasuda H., Uno T. J. Chromatogr. 377:1986;269-277.
24. Martín J., Méndez R. J. Liq. Chromatogr. 11:1988;1697-1705.
25. United States Pharmacopeia 23, Section 1225, Validation of Compendial Methods, United States Pharmacopeia Convention, Inc., Rockville, MD, 1995.
26. Bressolle F., Bromet-Petit M., Audran M. J. Chromatogr. B. 686:1996;3-10.
27. Peng G.W., Chiou W.L. J. Chromatogr. B. 531:1990;3-50.
28. Parra A., Garcia-Villanova J., Rodenas V., Gomez M.D. J. Pharm. Biomed. Anal. 12:1994;653-657.
29. Mahgoub H., Aly F.A. J. Pharm. Biomed. Anal. 17:1998;1723-1728.
30. Rosing H., Man Y.W., Doyle E., Bult A., Beijnen J.H. J. Liq. Chromatogr. Related Technol. 23:2000;329-354.
31. International Conference on Harmonization, Note for Guidance on Validation of Analytical Procedures: Methodology, Committee for Proprietary Medical Products, CPMP/ICH/281/95, Approval 18 December 1996.
32. Braggio S., Barnaby R.J., Grossi P., Cugola M. J. Pharm. Biomed. Anal. 14:1996;375-388.
33. H. Hill, Proceedings of Analytical Validation: A Practical Approach to Meet Current Regulatory Requirements, Management Forum, London, 1994.
34. Wieling J., Hendricks G., Tamminga W.J., Hempenius J., Mensink C.K., Oosterhuis B., Jonkman J.H.G. J. Chromatogr. A. 730:1996;381-394.
35. L. Shargel, A.B.C. Yu, Applied Biopharmaceutics and Pharmacokinetics, 3rd. ed., Prentice-Hall, New York, 1993, pp. 47-76.
36. Hartmann C., Smeyers-Verbeke J., Massart D.L., McDowall R.D. J. Pharm. Biomed. Anal. 17:1998;193-218.
37. Hubert Ph., Chiap P., Crommen J., Boulanger B., Chapuzet E., Mercier N., Bervoas-Martin S., Chevalier P., Grandjean D., Lagorce P., Lallier M., Laparra M.C., Laurentie M., Nivet J.C. Anal. Chim. Acta. 391:1999;135-148.